Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Q2 EBITDA Up At SEK 327 Mln

July 17 (Reuters) - Vitrolife AB  VITR.ST :
    * INTERIM REPORT Q2, 2024: STRONG TECHNOLOGIES GROWTH AND
IMPROVED
MARGINS
    * Q2 SALES OF SEK 941 (905) MILLION, AN INCREASE OF 4% IN
LOCAL
CURRENCIES AND 4% IN SEK
    * Q2 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) INCREASED TO SEK 327 (293) MILLION

Source text for Eikon:  ID:nWkr9FjNBm 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Vitrolife AB

See all news